Navigation Links
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
Date:6/25/2009

effect -- can be a real breakthrough in CF patients' arduous treatment burden , and are looking forward to seeing the Phase II results and moving to Phase III soon afterward," said Tim Whitten, Transave's President and Chief Executive Officer. "We are grateful for the continued support of the CF Foundation as we strive to improve treatment options for CF patients."

The double-blind, 3 cohort, placebo-controlled study is designed to evaluate ARIKACE in the treatment of CF patients with Pseudomonas lung infections. A total of 46 patients have been randomized. ARIKACE or placebo are administered once daily for 28 days using an eFlow(R) Nebulizer System (PARI Pharma GmbH), a novel, highly efficient, portable aerosol delivery system. Eighteen clinical sites throughout the United States are participating in the study.

About ARIKACE(TM)

ARIKACE is a sustained-release formulation of the antibiotic amikacin, which encloses the drug in nanocapsules of lipid called liposomes. This advanced pulmonary liposome technology prolongs the release of amikacin in the lungs while minimizing systemic exposure. The treatment uses biocompatible lipids endogenous to the lung that are formulated into small (0.3 micron), neutral liposomes that enable penetration of the biofilm and are highly efficient, with a very low lipid-to-drug ratio (0.65). ARIKACE can be delivered through nebulization, which enables the small aerosol droplet size (1 to 5 microns) to facilitate more effective distribution in the lungs.

Positive Phase II results were announced in June 2008 from a clinical trial in European CF patients with Pseudomonas lung infections. The company also previously announced completion of enrollment in another Phase II trial in which ARIKACE is being evaluated in the treatment of non-CF patients who have bronchiectasis with Pseudomonas lung infections. In the
'/>"/>

SOURCE Transave, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Professional Compounding Centers ... medicine by awarding the three best scientific presentations ... (EuPFI) conference . The Formulating Better Medicines ... in Athens, Greece , includes ... and professionals, from which three winners will be ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
(Date:8/20/2014)... Aug. 20, 2014 The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kansas blocked the sale of more ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 Medizone International, Inc. (MZEI:OB MZEI:QB) reports ... Patent No 2735739 for processes and systems relating ... AsepticSure™ hospital disinfection product. Medizone,s ... significance of this Grant: "This foundational lead patent ...
... Leading event organiser UBM has announced a record ... pharmaceutical events including CPhI Worldwide for pharmaceutical ingredients, ... for equipment, machinery and technology and the new ... Frankfurt, Germany from the 25th to 27th October ...
Cached Medicine Technology:Canadian Patent Issued to Medizone International for AsepticSureā„¢ Disinfection Technology 2Record Year for UBM's Pharma Events in Frankfurt 2Record Year for UBM's Pharma Events in Frankfurt 3Record Year for UBM's Pharma Events in Frankfurt 4
(Date:8/21/2014)... Physicians (CHEST) announces the immediate release of Care ... and Disasters: CHEST Consensus Statement today in the ... while the global health-care community cares for ... aims to guide ethical decision-making, coordination of care, ... was developed by over 100 clinicians and experts ...
(Date:8/21/2014)... When children go back to school, they ... them to become sick and risk missing school. It is ... them fight these germs to ensure a successful school year. ... that with its XFactor program. , The XFactor program supports ... Children ages 4 and up can receive 30-day supplies of ...
(Date:8/21/2014)... 21, 2014 CarePoint Health is ... P. Patel, MD, and Sujoy Menon, MD, have ... Patel and Dr. Menon to the community. CarePoint ... diagnostic imaging services to patients in Hudson County ... Christ Hospital and Hoboken University Medical Center. Our ...
(Date:8/21/2014)... of Utah scientists have developed a genetically engineered line ... to new research on epilepsy, Alzheimer,s and other diseases. ... changes in degree of fluorescence in response to different ... cells called astrocytes and microglia, to be studied in ... possibility to decipher how the brain works," said ...
(Date:8/21/2014)... Individuals with schizophrenia often have trouble engaging in ... new study from San Francisco State University suggests the ... of effort required to complete tasks. , The research, ... Journal of Abnormal Psychology , can assist health ... and help those patients function normally by breaking up ...
Breaking Medicine News(10 mins):Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:MedX Pharmacy Helps with Back to School Preparation 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2
... Javier Menendez and colleagues from Northwestern University have found ... drug found to be effective in reducing the cancer ... have Her-2/neu receptors (Human Epidermal Growth factor Receptor type ... are more aggressive and the activation of the receptors ...
... name suggests is the excessive accumulation of fat in the ... may be a crucial one in explaining the association between ... concluded from the study that persons with fatty liver may ... ,The study was conducted among a group of 1,455 individuals ...
... Cape Town, South Africa have found effective results using ... women with high-risk for //,cervical cancer using low resource ... study results showed that the test and treat program ... of cervical cancer and precancerous cervical lesions. ...
... in action or effect of a particular drug than the individual ... in the present scenario where the avian bird flu is posing ... ,Tamiflu is a prescribed drug for seasonal flu, ... H5N1 bird flu circulating in Asia and reported in other areas ...
... Association for Cancer Research has leaned in a big way ... garlic after several studies presented at the meeting extolled on ... with irrefutable news, experts are now of the view that ... change the way you eat, in other words diet modification ...
... Delhi: India, which is currently ... flu, is thinking of importing ... for poultry said a government ... also has set up special ...
Cached Medicine News:Health News:Primrose oil reduces Breast cancer cell growth 2Health News:Persons With Fatty Liver More Prone For Hypertension 2Health News:Two screen test and treat screening for cervical cancer 2Health News:Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid 2
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... variety of applications. • Whole pipette is autoclavable ... rotated against the handle to work in a ... towards the microtiter plate. • The special nose ... pipette tips, and provides a firm, parallel fit. ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
Medicine Products: